CH Tianbao GP (01427): Chen Zhu appointed as independent non-executive director.
China Tian Bao Group (01427) announced that Ms. Chen Zhu has been appointed as an independent non-executive director. The members of the Board Audit Committee, Board Remuneration Committee, Board Nomination Committee, Board Investment Decision Committee, and Board Strategic Planning Committee will take effect from January 21, 2026.
CH TIANBAO GP (01427) announced that Ms. Chen Zhu has been appointed as an independent non-executive director. She will also be a member of the Board Audit Committee, Board Remuneration Committee, Board Nomination Committee, Board Investment Decision Committee, and Board Strategic Planning Committee, effective from January 21, 2026.
Related Articles

Guangdong Zhongsheng Pharmaceutical (002317.SZ): The innovative drug Arlaidevir project has received top-line analysis data results from two Phase III clinical trials.

New stock news | Luku Technology submits application to the Hong Kong Stock Exchange, the shipment volume of vein smart locks in 2024 ranks first in the world.

Hunan Silver (002716.SZ) director Rongqi resigns
Guangdong Zhongsheng Pharmaceutical (002317.SZ): The innovative drug Arlaidevir project has received top-line analysis data results from two Phase III clinical trials.

New stock news | Luku Technology submits application to the Hong Kong Stock Exchange, the shipment volume of vein smart locks in 2024 ranks first in the world.

Hunan Silver (002716.SZ) director Rongqi resigns

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


